Heart surgeon dedicates career to helping patients no one else can save

Early excellence

Jeevanandam spent the first decade of his life in Tuticorin on India’s southern tip until he, his parents and older sister immigrated to New York City in 1970. At age 15, he was accepted to Columbia University, where he would graduate summa cum laude and earned the school’s top awards in surgery, medicine and physiology during his final year.

His mentor at Columbia was Eric Rose, a pioneer in the field of cardiothoracic surgery and the first surgeon to perform a successful pediatric heart transplant. Rose described Jeevanandam as being “insatiably curious” and “an incredibly special human being, who is brilliant, energetic and compassionate.”

It was perhaps this curiosity that led Jeevanandam to leave New York after 22 years to start a career at Temple University. He anticipated working alongside Temple’s senior surgeon, but that plan was dashed when, just months after Jeevanandam took the position, the entire heart transplant physician team left for another hospital.

Promoted to director of the heart transplant program, Jeevanandam performed 52 heart transplants that year—shattering the hospital’s previous record. Initially, though, the young surgeon had doubts. He called Rose to seek advice on whether to stay.

“Eric said, ‘You stay and get the job done.’ And that’s always been my theme,” he recalled. “I want to think outside the box and do something different. Instead of reading about it first and then doing it, I’d rather create it and then write about it for other people to read and learn from.”

Helping the helpless

When he was 8, Jeevanandam watched his grandfather collapse from a massive heart attack and die. From then on, he became fascinated with how to help others and was drawn to heart transplant because of the intellectual and technical challenges.

He has relentlessly sought innovative ways to save lives. That includes perfecting so-called bloodless cardiac surgeries for patients, such as Jehovah’s Witnesses—who will not accept blood transfusions—and conducting pioneering research on mechanical assist devices to provide a bridge to transplant or a long-term solution for patients who may not be transplant candidates.

Colleen LaBuhn, UChicago Medicine’s cardiac surgery program coordinator, admires how Jeevanandam never gives up on patients, even when the most sick, complicated or underinsured are sent his way.

“He will fight for patients who have nothing,” she said. “He thrives on helping people nobody else can really help.”

A heart to give back

Jeevanandam is one of the last pioneers of heart transplant and mechanical assist devices still practicing medicine. And for a man with numerous accolades, awards, publications and records, one would expect a commensurate ego.

However, the very nature of transplant—the lack of complete control even when a procedure is performed technically perfectly—has driven him to a devout spirituality.

“In my faith, we are told ego is the biggest problem in the world,” he said. “If you think it’s all you doing it, then that becomes a real barrier. It’s not ‘I,’ but the collective ‘we’ who have been entrusted with a person’s life.”

Leilani Miles has worked alongside him in the operating room for all 22 of his years at UChicago Medicine. Jeevanandam has high expectations of his team members, she said, but he also treats them with the utmost respect. She points to the 10- and 15-year tenures of many colleagues as a testament to the loyalty they have, to their patients and to Jeevanandam.

“We see a lot of high-risk patients, people no other hospitals will take,” she said. “But Val is always calm, and that sets the tone for the entire team. He’ll never say no unless he’s truly maximized all of his options to save someone.”

Strong proponents of education as a way to end cyclical poverty, Jeevanandam and his family created a fund to support children in India who have dreams of attending college but no resources to get them there. Currently, they support nine students per year, and he’s looking to expand that. Additionally, he makes annual trips back to Puttaparthi in his home country to perform volunteer surgeries, a commitment he has honored for the past 24 years.

Another milestone in medicine

For 2020, he has set his sights on conquering one of the biggest remaining barriers to transplant: antibody rejection rates.

Some people develop antibodies that will attack donated organs at much higher rates than normal, drastically limiting their pool of available organs and a transplant’s chances of success. No reliable method exists for decreasing antibodies. But Jeevanandam’s research and extensive experience with multi-organ transplants have shown that the body’s most effective way of eliminating these agents is through a liver — which acts like a sponge — that belongs to the same body as the heart.

What if a patient has a failing heart but a healthy liver? Jeevanandam and his team are working to perfect the domino transplant, in which the patient with a failing heart would receive both a new heart and a new liver and would donate the healthy liver to a different person with a failing one.

They aren’t there yet, but their success could mean a lifesaving breakthrough for those who previously had no hope. It also could be the capstone to an already impressive career. But Jeevanandam doesn’t think like that.

“Every day, I do as much as I can, but, ultimately, the pressure is off,” he said. “If the cosmos wants it to happen, it will.”

—Adapted from a story that first appeared on the UChicago Medicine website.